Rapid Micro Biosystems, Inc. (RPID)

Market Cap	106.84M -5.7%
Revenue (ttm)	33.59M +19.7%
Net Income	-47.12M
EPS	-1.05
Shares Out	45.46M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	276,448
Open	2.470
Previous Close	2.500
Day's Range	2.290 - 2.540
52-Week Range	1.860 - 4.940
Beta	1.39
Analysts	Strong Buy
Price Target	8.00 (+240.43%)
Earnings Date	Mar 12, 2026

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquat...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 15, 2021
• Employees: 163
• Stock Exchange: NASDAQ
• Ticker Symbol: RPID
• Website: https://www.rapidmicrobio.com

Financial Performance

In 2025, Rapid Micro Biosystems's revenue was $33.59 million, an increase of 19.74% compared to the previous year's $28.05 million. Losses were -$47.12 million, 0.50% more than in 2024.

Analyst Summary

According to one analyst, the rating for RPID stock is "Strong Buy" and the 12-month stock price target is $8.0.

Price Target

$8.0

(240.43% upside)

Analyst Consensus: Strong Buy